Artal Group S.A. Omega Therapeutics, Inc. Transaction History

Artal Group S.A.

  • $214 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$1.35 - $3.21 $1.63 Million - $3.88 Million
-1,209,515 Reduced 47.75%
1,323,530 $3.98 Million
Q1 2023

May 12, 2023
BUY
$4.81 - $10.95 $1.25 Million - $2.84 Million
259,515 Added 11.41%
2,533,045 $15.3 Million
Q3 2021

Nov 12, 2021
BUY
$16.0 - $22.51 $36.4 Million - $51.2 Million
2,273,530 New
2,273,530 $42.9 Million

Others Institutions Holding OMGA

# of Institutions
58
Shares Held
43.4M
Call Options Held
25.8K
Put Options Held
7K
View Full List

About Omega Therapeutics, Inc.

OMGA Quotes by TradingView
  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $37.8M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email